(NYSEMKT: INFU) Infusystem Holdings's forecast annual revenue growth rate of 4.94% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.62%.
Infusystem Holdings's revenue in 2025 is $141,054,000.On average, 7 Wall Street analysts forecast INFU's revenue for 2025 to be $2,984,944,941, with the lowest INFU revenue forecast at $2,857,640,435, and the highest INFU revenue forecast at $3,100,657,822. On average, 7 Wall Street analysts forecast INFU's revenue for 2026 to be $3,094,353,605, with the lowest INFU revenue forecast at $2,927,800,267, and the highest INFU revenue forecast at $3,213,726,999.
In 2027, INFU is forecast to generate $3,346,115,551 in revenue, with the lowest revenue forecast at $3,191,357,198 and the highest revenue forecast at $3,469,962,905.